Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PA) Long-Term Debt Repayments (2017 - 2025)

Historic Long-Term Debt Repayments for Global Medical REIT (GMRE-PA) over the last 10 years, with Q3 2025 value amounting to $11.8 million.

  • Global Medical REIT's Long-Term Debt Repayments fell 6000.0% to $11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.5 million, marking a year-over-year increase of 1060.21%. This contributed to the annual value of $99.6 million for FY2024, which is 2697.95% down from last year.
  • As of Q3 2025, Global Medical REIT's Long-Term Debt Repayments stood at $11.8 million, which was down 6000.0% from $15.0 million recorded in Q2 2025.
  • In the past 5 years, Global Medical REIT's Long-Term Debt Repayments ranged from a high of $151.8 million in Q1 2021 and a low of $282000.0 during Q1 2022
  • Its 5-year average for Long-Term Debt Repayments is $30.4 million, with a median of $17.0 million in 2021.
  • In the last 5 years, Global Medical REIT's Long-Term Debt Repayments tumbled by 9981.42% in 2022 and then surged by 514822.7% in 2023.
  • Global Medical REIT's Long-Term Debt Repayments (Quarter) stood at $17.0 million in 2021, then crashed by 38.24% to $10.5 million in 2022, then surged by 100.0% to $21.0 million in 2023, then skyrocketed by 110.48% to $44.2 million in 2024, then crashed by 73.3% to $11.8 million in 2025.
  • Its last three reported values are $11.8 million in Q3 2025, $15.0 million for Q2 2025, and $13.5 million during Q1 2025.